US · Healthcare

Xilio Development Inc (XLO)

Biotechnology

Xilio Development Inc (XLO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for XLO

P/E ratio

25.00

Xilio Development Inc (XLO) — FAQ

What is XLO's P/E ratio?

The price-to-earnings (P/E) ratio for Xilio Development Inc (XLO) is 25.00 (data as of 2026-05-23).

Does Xilio Development Inc pay a dividend?

Dividend yield is not available in the current snapshot for Xilio Development Inc (XLO). Check the MyAverix Finance app for the latest dividend data.

What sector is Xilio Development Inc in?

Xilio Development Inc (XLO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is XLO listed on?

XLO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)